Halxim 200 DT Tablet contains Cefixime 200mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is indicated for the treatment of various infections caused by susceptible strains of bacteria, including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, uncomplicated gonorrhea, otitis media, and pharyngitis/tonsillitis. Halxim 200 DT is formulated as a dispersible tablet, facilitating ease of administration, particularly in pediatric and geriatric populations. The drug demonstrates excellent oral bioavailability and is primarily excreted unchanged via the kidneys. Dosage and duration of therapy should be determined based on the severity and type of infection, patient age, and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions including rash and pruritus. Caution is advised in patients with a history of penicillin or cephalosporin allergy. It is contraindicated in individuals with known hypersensitivity to Cefixime or other cephalosporins. Use during pregnancy and lactation should be under medical supervision. Proper adherence to prescribed dosage is essential to prevent resistance development.